Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
Molina B, Padoan R, Urban ML, Novikov P, Caminati M, Taillé C, Néel A, Bouillet L, Fraticelli P, Schleinitz N, Christides C, Moi L, Godeau B, Knight A, Schroeder JW, Marchand-Adam S, Gil H, Cottin V, Durel CA, Gelain E, Lerais B, Ruivard M, Groh M, Samson M, Moroni L, Thiel J, Kernder A, Cohen Tervaert JW, Costanzo G, Folci M, Rizzello S, Cohen P, Emmi G, Terrier B. Molina B, et al. Among authors: groh m. Ann Rheum Dis. 2023 Dec;82(12):1587-1593. doi: 10.1136/ard-2023-224756. Epub 2023 Sep 21. Ann Rheum Dis. 2023. PMID: 37734881
Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia.
Delcros Q, Taillé C, Vallée A, Brun AL, Chenivesse C, Couture P, Daboussi S, Guilleminault L, Juster F, Kahn JE, Lefèvre G, Liozon E, Magnan A, Meireles S, Moulis G, Puech C, Tcherakian C, Traclet J, Uzunhan Y, Cottin V, Groh M; CEREO, OrphaLung, and CRISALIS Networks. Delcros Q, et al. Among authors: groh m. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1317-1319.e1. doi: 10.1016/j.jaip.2022.12.022. Epub 2022 Dec 26. J Allergy Clin Immunol Pract. 2023. PMID: 36581069 No abstract available.
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh M, Rohmer J, Etienne N, Abou Chahla W, Baudet A, Chan Hew Wai A, Chenivesse C, Clisson Rusek I, Cottin V, Decamp M, De Groote P, Delahousse F, Duployez N, Faguer S, Gottrand F, Huang F, Leblanc T, Magnan A, Martin T, Mortuaire G, Néel A, Paris L, Petit A, Rossignol J, Schleinitz N, Soret-Dulphy J, Staumont-Salle D, Terrier B, Terriou L, Viallard JF, Lefèvre G, Kahn JE. Groh M, et al. Orphanet J Rare Dis. 2023 Apr 30;18(1):100. doi: 10.1186/s13023-023-02696-4. Orphanet J Rare Dis. 2023. PMID: 37122022 Free PMC article.
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients.
Rohmer J, Nguyen Y, Trefond L, Agard C, Allain JS, Berezne A, Charles P, Cohen P, Gondran G, Groh M, Huscenot T, Lacout C, Lazaro E, London J, Maurier F, Mekinian A, Mesbah R, Nubourgh I, Perard L, Puéchal X, Pugnet G, Puyade M, Queyrel V, Roux A, Rouzaud D, Durel CA, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Rohmer J, et al. Among authors: groh m. J Autoimmun. 2023 Sep;139:103093. doi: 10.1016/j.jaut.2023.103093. Epub 2023 Aug 1. J Autoimmun. 2023. PMID: 37536165
Benralizumab for eosinophilic granulomatosis with polyangiitis.
Cottu A, Groh M, Desaintjean C, Marchand-Adam S, Guillevin L, Puechal X, Beaumesnil S, Lazaro E, Samson M, Taille C, Durel CA, Diot E, Nicolas S, Guilleminault L, Ebbo M, Cathebras P, Dupin C, Yildiz H, Belfeki N, Pugnet G, Chauvin P, Jouneau S, Lifermann F, Martellosio JP, Cottin V, Terrier B; French Vasculitis Study Group. Cottu A, et al. Among authors: groh m. Ann Rheum Dis. 2023 Dec;82(12):1580-1586. doi: 10.1136/ard-2023-224624. Epub 2023 Aug 7. Ann Rheum Dis. 2023. PMID: 37550002
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: A nationwide CEREO study.
Groh M, Fenwarth L, Labro M, Boudry A, Fournier E, Wemeau M, Marceau-Renaut A, Daltro de Oliveira R, Abraham J, Barry M, Blanche P, Bodard Q, Braun T, Chebrek S, Decamp M, Durel CA, Forcade E, Gerfaud-Valentin M, Golfier C, Gourguechon C, Grardel N, Kosmider O, Martis N, Melboucy Belkhir S, Merabet F, Michon A, Moreau S, Morice C, Néel A, Nicolini FE, Pascal L, Pasquier F, Pieragostini A, Roche-Lestienne C, Rousselot P, Terriou L, Thiebaut-Bertrand A, Viallard JF, Preudhomme C, Kahn JE, Lefevre G, Duployez N; CEREO Collaborators. Groh M, et al. Am J Hematol. 2024 Apr 2. doi: 10.1002/ajh.27306. Online ahead of print. Am J Hematol. 2024. PMID: 38563187
IgG4-related uveitis. A French cohort and literature review.
Stuchfield-Denby E, De Sainte Marie B, Hie M, Hatchuel Y, Gerber A, Bencheikh S, Pugnet G, Groh M, Farhat MM, Urbina D, Ebbo M, Schleinitz N. Stuchfield-Denby E, et al. Among authors: groh m. Semin Arthritis Rheum. 2024 Feb;64:152278. doi: 10.1016/j.semarthrit.2023.152278. Epub 2023 Nov 11. Semin Arthritis Rheum. 2024. PMID: 38000318 Review.
390 results